Heron Therapeutics (HRTX) Capital Expenditures Growth (3y) (2013 - 2026)
Heron Therapeutics (HRTX) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Heron Therapeutics |
76.81 Mn |
46.84 Mn |
24.07 Mn |
20.40% |
| Date | Value |
|---|
| Mar 31, 2026 |
20.40% |
| Jun 30, 2025 |
-13.56% |
| Mar 31, 2025 |
-52.91% |
| Dec 31, 2024 |
17.83% |
| Sep 30, 2024 |
-34.46% |
| Dec 31, 2023 |
-53.55% |
| Sep 30, 2023 |
7.86% |
| Jun 30, 2023 |
-28.13% |
| Mar 31, 2023 |
-57.60% |
| Dec 31, 2022 |
-52.66% |
| Sep 30, 2022 |
26.89% |
| Jun 30, 2022 |
-47.00% |
| Mar 31, 2022 |
-21.23% |
| Dec 31, 2021 |
-51.76% |
| Sep 30, 2021 |
-23.78% |
| Jun 30, 2021 |
-38.19% |
| Mar 31, 2021 |
-4.56% |
| Dec 31, 2020 |
30.05% |
| Sep 30, 2020 |
404.49% |
| Jun 30, 2020 |
15.51% |
